Europol records surge in fake pharma goods during COVID-19 crisis
Demand for counterfeit products, particularly fake pharmaceutical and healthcare products, has surged and will continue throughout the current COVID-19 crisis, despite potentially harmful effects on consumers, according to Europol.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
10 August 2020 As the pandemic increases the risk of online fraud, one company is helping brands fight back. WIPR met with Stuart Fuller of CentralNIC Group to find out more.
30 November 2020 Nearly 22,000 domain names offering counterfeit and pirated items over the internet have been seized as part of ‘In Our Sites’, a joint international operation.
29 November 2022 Production of counterfeit products increasingly taking place within the EU | Overlap of IP crimes with tax evasion and money laundering |
Interpol | Europol | Eurojust.